Evaluation of a new immunoassay to measure sirolimus blood concentrations compared to a tandem mass-spectrometric chromatographic analysis.

Fillée, C;Mourad, Michel;Squifflet, Jean-Paul;Malaise, Jacques;Wallemacq, Pierre;et.al.
(2005) Transplantation Proceedings — Vol. 37, n° 6, p. 2890-2891 (2005)

Files

10339.pdf
  • Restricted Access
  • Adobe PDF
  • 59.31 KB

Details

Authors
  • Fillée, CUCLouvain
    Author
  • Mourad, MichelUCLouvain
    Author
  • Squifflet, Jean-PaulUCLouvain
    Author
  • Malaise, JacquesUCLouvain
    Author
  • Lerut, JanUCLouvain
    Author
  • Reding, RaymondUCLouvain
    Author
  • Borghgraef, PUCLouvain
    Author
  • Vanbinst, R.UCLouvain
    Author
  • Wallemacq, PierreUCLouvain
    Author
Show more
Abstract
A new immunoassay of sirolimus based on the microparticle enzyme immunoassay (MEIA) principle has been developed with collaboration of Abbott Diagnostics. Laboratories and Axis-Shield. Our laboratory evaluated this new assay on 153 whole blood samples (EDTA) drawn from a population of renal (n = 141) and hepatic (n = 12) transplant patients. Each blood sample was analyzed simultaneously by MEIA (Y) and by a reference method (X) used routinely in our laboratory, namely, liquid chromatography tandem mass spectrometry (LC-MS/MS). The statistical analysis of Passing-Bablok produced the following results: Spearman r value = 0.95, slope = 1.15 and intercept with the Y axis = +0.2 ng/mL. The observed global overestimation of 15% compared to the reference method could be explained by the cross-reactivity of sirolimus metabolites with the antibody. A complementary analysis taking into account the transplanted organ (kidney versus hepatic) did not show any significant difference between the populations, most likely owing to the low number of hepatic transplantation samples. The analytical performance of the MEIA method showed CV < or =10% and a limit of quantification of 1.5 ng/mL, which were acceptable for routine clinical monitoring. In conclusion, the MEIA method has shown robust, stable, reproducible, features with an excellent correlation with the reference LC-MS/MS method.
Affiliations

Citations

Fillée, C., Mourad, M., Squifflet, J.-P., Malaise, J., Lerut, J., Reding, R., Borghgraef, P., Vanbinst, R., & Wallemacq, P. (2005). Evaluation of a new immunoassay to measure sirolimus blood concentrations compared to a tandem mass-spectrometric chromatographic analysis. Transplantation Proceedings, 37(6), 2890-2891. https://doi.org/10.1016/j.transproceed.2005.05.034 (Original work published 2005)